Ixabepilone + Carboplatin Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Ixabepilone|DRUG: Carboplatin
Sponsor: US Oncology Research
Collaborators: Bristol-Myers Squibb